Literature DB >> 11207491

Prevalence of depressive symptoms in late pregnancy and postpartum.

A Josefsson1, G Berg, C Nordin, G Sydsjö.   

Abstract

BACKGROUND: Postnatal depression refers to a non-psychotic depressive episode that begins in or extends into the postpartum period. The aims of this study were to examine the prevalence of depressive symptoms in a pregnant and later postnatal population, to determine the natural course of these symptoms and whether there is an association between antenatal and postnatal depressive symptomatology.
METHODS: A longitudinal study with a total population of 1,558 consecutively registered pregnant women in the southeast region of Sweden. Presence of depressive symptoms was measured with the Edinburgh Postnatal Depression Scale on four occasions namely in gestational week 35-36, in the maternity ward, 6-8 weeks and 6 months postpartum.
RESULTS: The prevalence of depressive symptoms during late pregnancy was 17%; in the maternity ward 18%; 6-8 weeks postnatally 13%; and 6 months postnatally, 13%. A correlation between antenatal and postnatal depressive symptoms was found (r=0.50, p<0.0001).
CONCLUSION: Detection of women at risk for developing postnatal depressive symptoms can be done during late pregnancy. Antenatal care clinics constitute a natural and useful environment for recognition of women with depressive symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11207491     DOI: 10.1034/j.1600-0412.2001.080003251.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  90 in total

1.  Major depressive disorder during pregnancy and emotional attachment to the fetus.

Authors:  Julie McFarland; Amy L Salisbury; Cynthia L Battle; Katheleen Hawes; Katherine Halloran; Barry M Lester
Journal:  Arch Womens Ment Health       Date:  2011-09-22       Impact factor: 3.633

2.  Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels.

Authors:  Lauren Osborne; Makena Clive; Mary Kimmel; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Jennifer Judy; Samantha Meilman; Aviva Braier; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Fernando Goes; Jennifer L Payne; Elisabeth B Binder; Zachary Kaminsky
Journal:  Neuropsychopharmacology       Date:  2015-10-27       Impact factor: 7.853

3.  Prenatal cocaine use and maternal depression: effects on infant neurobehavior.

Authors:  Amy L Salisbury; Barry M Lester; Ronald Seifer; Linda Lagasse; Charles R Bauer; Seetha Shankaran; Henrietta Bada; Linda Wright; Jing Liu; Ken Poole
Journal:  Neurotoxicol Teratol       Date:  2006-12-14       Impact factor: 3.763

Review 4.  The role of tryptophan metabolism in postpartum depression.

Authors:  Kai-Ming Duan; Jia-Hui Ma; Sai-Ying Wang; ZhengDong Huang; YingYong Zhou; HeYa Yu
Journal:  Metab Brain Dis       Date:  2018-01-06       Impact factor: 3.584

Review 5.  Implications of timing of maternal depressive symptoms for early cognitive and language development.

Authors:  Sara L Sohr-Preston; Laura V Scaramella
Journal:  Clin Child Fam Psychol Rev       Date:  2006-03

6.  High pregnancy-related anxiety and prenatal depressive symptoms as predictors of intention to breastfeed and breastfeeding initiation.

Authors:  Tarayn G Fairlie; Matthew W Gillman; Janet Rich-Edwards
Journal:  J Womens Health (Larchmt)       Date:  2009-07       Impact factor: 2.681

7.  Mania and depression in the perinatal period among women with a history of major depressive disorders.

Authors:  Angela J Inglis; Catriona L Hippman; Prescilla B Carrion; William G Honer; Jehannine C Austin
Journal:  Arch Womens Ment Health       Date:  2014-01-09       Impact factor: 3.633

8.  Oxytocin receptor DNA methylation in postpartum depression.

Authors:  Mary Kimmel; Makena Clive; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Lauren M Osborne; Elisabeth Binder; Jennifer L Payne; Zachary Kaminsky
Journal:  Psychoneuroendocrinology       Date:  2016-04-08       Impact factor: 4.905

9.  Neonatal intensive care unit admission and maternal postpartum depression.

Authors:  Tara Wyatt; Karina M Shreffler; Lucia Ciciolla
Journal:  J Reprod Infant Psychol       Date:  2018-11-19

10.  In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder.

Authors:  Nicole B Gidaya; Brian K Lee; Igor Burstyn; Michael Yudell; Erik L Mortensen; Craig J Newschaffer
Journal:  J Autism Dev Disord       Date:  2014-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.